Literature DB >> 25194175

The gut-brain axis in obesity.

Helena Buhmann1, Carel W le Roux2, Marco Bueter3.   

Abstract

Currently the only effective treatment for morbid obesity with a proven mortality benefit is surgical intervention. The underlying mechanisms of these surgical techniques are unclear, but alterations in circulating gut hormone levels have been demonstrated to be at least one contributing factor. Gut hormones seem to communicate information from the gastrointestinal tract to the regulatory appetite centres within the central nervous system (CNS) via the so-called 'Gut-Brain-Axis'. Such information may be transferred to the CNS either via vagal or non-vagal afferent nerve signalling or directly via blood circulation. Complex neural networks, distributed throughout the forebrain and brainstem, are in control of feeding and energy homoeostasis. This article aims to review how appetite is potentially regulated by these gastrointestinal hormones. Identification of the underlying mechanisms of appetite and weight control may pave the way to develop better surgical techniques and new therapies in the future.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Appetite; Gastrointestinal hormones; Glucagon-like-peptide 1 (GLP-1); Hypothalamus; Obesity

Mesh:

Substances:

Year:  2014        PMID: 25194175     DOI: 10.1016/j.bpg.2014.07.003

Source DB:  PubMed          Journal:  Best Pract Res Clin Gastroenterol        ISSN: 1521-6918            Impact factor:   3.043


  26 in total

Review 1.  Do Food Preferences Change After Bariatric Surgery?

Authors:  Daniel Gero; Robert E Steinert; Carel W le Roux; Marco Bueter
Journal:  Curr Atheroscler Rep       Date:  2017-09       Impact factor: 5.113

Review 2.  Dietary fiber and satiety: the effects of oats on satiety.

Authors:  Candida J Rebello; Carol E O'Neil; Frank L Greenway
Journal:  Nutr Rev       Date:  2016-01-02       Impact factor: 7.110

3.  Dietary Polysaccharides in the Amelioration of Gut Microbiome Dysbiosis and Metabolic Diseases.

Authors:  Shokouh Ahmadi; Rabina Mainali; Ravinder Nagpal; Mahmoud Sheikh-Zeinoddin; Sabihe Soleimanian-Zad; Shaohua Wang; Gagan Deep; Santosh Kumar Mishra; Hariom Yadav
Journal:  Obes Control Ther       Date:  2017-12-18

4.  Bariatric and Metabolic Therapies Targeting the Small Intestine.

Authors:  Thomas R McCarty; Christopher C Thompson
Journal:  Tech Innov Gastrointest Endosc       Date:  2020-06-24

5.  Appetite regulating genes in zebrafish gut; a gene expression study.

Authors:  Ehsan Pashay Ahi; Mathilde Brunel; Emmanouil Tsakoumis; Junyu Chen; Monika Schmitz
Journal:  PLoS One       Date:  2022-07-19       Impact factor: 3.752

6.  Attenuated Weight Gain with the Novel Analog of Olanzapine Linked to Sarcosinyl Moiety (PGW5) Compared to Olanzapine.

Authors:  Michal Taler; Israel Vered; Rea Globus; Liat Shbiro; Abraham Weizman; Aron Weller; Irit Gil-Ad
Journal:  J Mol Neurosci       Date:  2015-11-14       Impact factor: 3.444

Review 7.  Brain-gut-microbiome interactions in obesity and food addiction.

Authors:  Arpana Gupta; Vadim Osadchiy; Emeran A Mayer
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2020-08-27       Impact factor: 46.802

8.  Plasma orexin-A level associated with physical activity in obese people.

Authors:  Yuan-Yuan Hao; Hong-Wang Yuan; Peng-Hua Fang; Yu Zhang; Yue-Xia Liao; Chen Shen; Dan Wang; Ting-Ting Zhang; Ping Bo
Journal:  Eat Weight Disord       Date:  2016-04-01       Impact factor: 4.652

Review 9.  Interventional treatment of obesity and diabetes: An interim report on gastric electrical stimulation.

Authors:  Harold E Lebovitz
Journal:  Rev Endocr Metab Disord       Date:  2016-03       Impact factor: 6.514

Review 10.  Increasing GLP-1 Circulating Levels by Bariatric Surgery or by GLP-1 Receptor Agonists Therapy: Why Are the Clinical Consequences so Different?

Authors:  Chloé Amouyal; Fabrizio Andreelli
Journal:  J Diabetes Res       Date:  2016-06-12       Impact factor: 4.011

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.